AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17679017 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection with 4% acetic acid (VIA) screening
Number of subjects: 49311
Study 17679017 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 49311
Study 16352489 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte depleting filter
Number of subjects: 20
Study 16352489 — intervention group
Group type: COMPARATOR
Intervention: Control group (no leukocyte filter)
Number of subjects: 20
Study 11867826 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (1000 microg daily) for 3 weeks
Number of subjects: 38
Study 11867826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 10223257 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys with depression
Number of subjects: 38
Study 10223257 — intervention group
Group type: COMPARATOR
Intervention: Boys without depression
Number of subjects: 38
Study 7849886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous theophylline (aminophylline)
Number of subjects: 42
Study 7849886 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 42
Study 2083923 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAMe) 800 mg/day i.v.
Number of subjects: 30
Study 2083923 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAMe)
Number of subjects: 30
Study 2083923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg metoprolol tablet
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg metoprolol tablet
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg metoprolol tablet
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% metoprolol eye drops
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% metoprolol eye drops
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% metoprolol eye drops
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% metoprolol eye drops
Number of subjects: 0
Study 7211263 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% metoprolol eye drops administered twice daily for 6 weeks
Number of subjects: 0
Study 31573939 — intervention group
Group type: EXPERIMENTAL
Intervention: ARMADILLO intervention (arm 1)
Number of subjects: 660
Study 31573939 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-a-week contact SMS text message (arm 2)
Number of subjects: 660
Study 31573939 — intervention group
Group type: COMPARATOR
Intervention: Usual care (arm 3)
Number of subjects: 660
Study 27665941 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitii™ (web-based program) for 20 weeks; n=51
Number of subjects: 102
Study 27665941 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control; n=50
Number of subjects: 102
Study 26279062 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedle array application
Number of subjects: 20
Study 26279062 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-prick lancet piercing
Number of subjects: 20
Study 26279062 — intervention group
Group type: COMPARATOR
Intervention: Adhesive-tape stripping
Number of subjects: 20
Study 22435646 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom promotion program (45-60 minutes, one-on-one session)
Number of subjects: 136
Study 22435646 — intervention group
Group type: COMPARATOR
Intervention: General health program (attention-matched comparison condition)
Number of subjects: 136
Study 21980653 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG (OPCABG)
Number of subjects: 60
Study 21980653 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 60
Study 19477358 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ANP (0.025 microg/kg/min for 3 days)
Number of subjects: 30
Study 19477358 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study 17320191 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for depression
Number of subjects: 151
Study 14996517 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 10 days
Number of subjects: 493
Study 14996517 — intervention group
Group type: COMPARATOR
Intervention: High-dose clarithromycin 500 mg twice daily for 10 days
Number of subjects: 493
Study 15014819 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 4 microg/kg and midazolam 0.04 mg/kg
Number of subjects: 40
Study 15014819 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 4 microg/kg
Number of subjects: 40
Study 9196677 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance enhancement strategy (extra education using video, booklets, posters, checklist, health care contract)
Number of subjects: 80
Study 9196677 — intervention group
Group type: COMPARATOR
Intervention: Standard level of contact lens instruction
Number of subjects: 80
Study 1947787 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg twice daily
Number of subjects: 19
Study 1947787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 6228473 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine alone
Number of subjects: 0
Study 6228473 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine in combination with Hepatitis B immunoglobulin
Number of subjects: 0
Study 6228473 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30894130 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot 2 methods (pre-notification, shorter questionnaire, personable materials, additional reminder, QR codes)
Number of subjects: 3000
Study 30894130 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot 2 methods (QR codes)
Number of subjects: 3000
Study 30894130 — intervention group
Group type: COMPARATOR
Intervention: Pilot 1 methods (baseline)
Number of subjects: 3000
Study 30894130 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot 2 methods (additional reminder)
Number of subjects: 3000
Study 29912819 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dilation
Number of subjects: 60
Study 29912819 — intervention group
Group type: COMPARATOR
Intervention: Control (continued medical therapy)
Number of subjects: 60
Study 27938375 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic support (cash transfers and payment of school fees)
Number of subjects: 4900
Study 27938375 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic support combined with a community intervention
Number of subjects: 4900
Study 25999242 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic HRV infections
Number of subjects: 502
Study 25999242 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic HRV infections
Number of subjects: 502
Study 25999242 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 502
Study 22715981 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 138)
Number of subjects: 290
Study 22715981 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 152)
Number of subjects: 290
Study 20302673 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous iliac crest graft (AICG)
Number of subjects: 258
Study 20302673 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK cage
Number of subjects: 258
Study 20302673 — intervention group
Group type: COMPARATOR
Intervention: Both AICG and PEEK cage
Number of subjects: 258
Study 18468575 — intervention group
Group type: EXPERIMENTAL
Intervention: History of unplanned pregnancy
Number of subjects: 542
Study 18468575 — intervention group
Group type: EXPERIMENTAL
Intervention: Young age and low educational status
Number of subjects: 542
Study 16330766 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (1,800 mg per os, single administration)
Number of subjects: 0
Study 12059873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone pulse therapy (group A)
Number of subjects: 33
Study 12059873 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone (group B)
Number of subjects: 33
Study 10472215 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibreoptic reflectance oximetry catheter
Number of subjects: 33
Study 10472215 — intervention group
Group type: COMPARATOR
Intervention: Bench oximeter
Number of subjects: 33
Study 8758124 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate 200 micrograms twice daily for six months
Number of subjects: 0
Study 8758124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1736604 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole 75 mg every 8 hours for 2 weeks
Number of subjects: 15
Study 1736604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1736604 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 15
Study 328328 — intervention group
Group type: COMPARATOR
Intervention: Penbutolol 25 mg and 50 mg (in 10 patients); 25 mg, 50 mg, and 100 mg (in 2 patients)
Number of subjects: 12
Study 328328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30762404 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling adjunct (LP1)
Number of subjects: 343
Study 30762404 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling adjunct (LP2)
Number of subjects: 343
Study 30762404 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling adjunct (LP3)
Number of subjects: 343
Study 29083433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement (150kcal, 20g whey protein, 800 IU vitamin D)
Number of subjects: 149
Study 29083433 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30kcal, non-nutritive)
Number of subjects: 149
Study 29083433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplement
Number of subjects: 149
Study 29083433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 25527336 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-recorded data on Hispanic ethnicity
Number of subjects: 569
Study 25527336 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-recorded data on African American race
Number of subjects: 569
Study 25527336 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-recorded language preference for Spanish
Number of subjects: 569
Study 25527336 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported identification with other racial or ethnic groups
Number of subjects: 569
Study 25527336 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-documented Spanish speakers
Number of subjects: 569
Study 25527336 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals recorded as English-speaking in EHR
Number of subjects: 569
Study 23001082 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (1 g ampicillin-sulbactam intravenously at anesthesia)
Number of subjects: 369
Study 23001082 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 369
Study 22108482 — intervention group
Group type: EXPERIMENTAL
Intervention: mf Odontovis Calcium® (calcium salts, Vitamin D, and physiological modulators with antioxidant activity)
Number of subjects: 79
Study 22108482 — intervention group
Group type: COMPARATOR
Intervention: Control group (best treatment without mf Odontovis Calcium®)
Number of subjects: 79
Study 22108482 — intervention group
Group type: EXPERIMENTAL
Intervention: mf Odontovis Calcium®
Number of subjects: 79
Study 19805640 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet supplemented with nuts
Number of subjects: 36
Study 19805640 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet supplemented with virgin olive oil
Number of subjects: 36
Study 22994061 — intervention group
Group type: EXPERIMENTAL
Intervention: pVIS + pIR radiation applied to the lumbar‐sacral region from days 1 to 7 after surgery
Number of subjects: 19
Study 22994061 — intervention group
Group type: COMPARATOR
Intervention: Standard course of postoperative rehabilitation (control)
Number of subjects: 19
Study 16167938 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma volume expansion and a diastolic BP target of 85-95 mmHg
Number of subjects: 216
Study 16167938 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fluid restriction and BP target of 95-105 mmHg
Number of subjects: 216
Study 14572325 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension administered with an Adaptive Aerosol Delivery (AAD) system
Number of subjects: 125
Study 14590596 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad mood induction
Number of subjects: 80
Study 14590596 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxious mood induction
Number of subjects: 80
Study 14590596 — intervention group
Group type: COMPARATOR
Intervention: Positive mood induction
Number of subjects: 80
Study 14590596 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 80
Study 14590596 — intervention group
Group type: COMPARATOR
Intervention: Paced Auditory Serial Addition Task (PASAT)
Number of subjects: 80
Study 2694097 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (Trental) intravenous treatment
Number of subjects: 39
Study 2694097 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (Trental) oral treatment
Number of subjects: 39
Study 2694097 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control) intravenous treatment
Number of subjects: 39
Study 365125 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature biofeedback with autogenic training and regular home practice
Number of subjects: 30
Study 365125 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation with regular home practice
Number of subjects: 30
Study 365125 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 30
Study 365125 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 30
Study 365125 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 30
Study 365125 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up data for both treated groups (biofeedback and relaxation)
Number of subjects: 30
Study 12799121 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental carbonated blackcurrant drink
Number of subjects: 15
Study 12799121 — intervention group
Group type: COMPARATOR
Intervention: Conventional carbonated orange drink
Number of subjects: 15
Study 12799121 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 15
Study 29439002 — intervention group
Group type: EXPERIMENTAL
Intervention: CTLB antenatal education programme
Number of subjects: 0
Study 29439002 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 27160473 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic surgery (VATS)
Number of subjects: 206
Study 27160473 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral thoracotomy
Number of subjects: 206
Study 25156178 — intervention group
Group type: EXPERIMENTAL
Intervention: V3P-brace
Number of subjects: 24
Study 25156178 — intervention group
Group type: EXPERIMENTAL
Intervention: VER-brace
Number of subjects: 24
Study 25156178 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL-brace
Number of subjects: 24
Study 22413453 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided short-axis group
Number of subjects: 36
Study 22413453 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided long-axis group
Number of subjects: 36
Study 22413453 — intervention group
Group type: COMPARATOR
Intervention: Blind palpation technique group
Number of subjects: 36
Study 20431975 — intervention group
Group type: EXPERIMENTAL
Intervention: physician advice
Number of subjects: 878
Study 20431975 — intervention group
Group type: EXPERIMENTAL
Intervention: assistance
Number of subjects: 878
Study 20431975 — intervention group
Group type: EXPERIMENTAL
Intervention: counseling
Number of subjects: 878
Study 18317392 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg prednisone for 5 days, followed by gradually reduced doses for an additional 15 days, and vestibular sedatives for symptomatic relief during the first 5 days.
Number of subjects: 30
Study 18317392 — intervention group
Group type: COMPARATOR
Intervention: Placebo and similar vestibular sedatives.
Number of subjects: 30
Study 16135860 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 347
Study 16135860 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 347
Study 11995347 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring (n = 20)
Number of subjects: 46
Study 11995347 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 46
Study 10102604 — intervention group
Group type: EXPERIMENTAL
Intervention: Full mouth series of radiographs
Number of subjects: 65
Study 10102604 — intervention group
Group type: COMPARATOR
Intervention: Panoramic radiographs
Number of subjects: 65
Study 10102604 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modalities (panoramic and full mouth series)
Number of subjects: 65
Study 8649929 — intervention group
Group type: EXPERIMENTAL
Intervention: DSSS system for detecting HCMV DNA
Number of subjects: 31
Study 8649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Agarose gel electrophoresis (ethidium bromide staining)
Number of subjects: 31
Study 8649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of HCMV DNA in urine samples
Number of subjects: 31
Study 8649929 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of specific anti-HCMV antibodies
Number of subjects: 31
Study 2121016 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator (rt-PA) followed by heparin
Number of subjects: 103
Study 2121016 — intervention group
Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 103
Study 526908 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubidazone (150 mg/m2 iv over 1 hour)
Number of subjects: 38
Study 526908 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin (60 mg/m2 iv over 5 minutes)
Number of subjects: 38
Study 526908 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin (60 mg/m2 iv over 5 minutes) after rubidazone failure
Number of subjects: 38
Study 526908 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubidazone
Number of subjects: 38
Study 526908 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin
Number of subjects: 38
Study 30552157 — intervention group
Group type: EXPERIMENTAL
Intervention: cFOLFOXIRI-BEV
Number of subjects: 280
Study 30552157 — intervention group
Group type: EXPERIMENTAL
Intervention: sFOLFOXIRI-BEV
Number of subjects: 280
Study 30552157 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX-BEV
Number of subjects: 280
Study 27178566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-coated probiotics (Duolac Care), 2 capsules per day, 5 billion bacteria per capsule for 4 weeks
Number of subjects: 50
Study 27178566 — intervention group
Group type: COMPARATOR
Intervention: Non-coated probiotics
Number of subjects: 50
Study 27178566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-coated probiotics
Number of subjects: 50
Study 25607519 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement (vitamin C:1000mg/d; vitamin E: 400 IU/d)
Number of subjects: 22
Study 25607519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 23782628 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue Pressure Profile Training (TPPT)
Number of subjects: 60
Study 23782628 — intervention group
Group type: COMPARATOR
Intervention: Tongue Pressure Strength-and-Accuracy Training (TPSAT)
Number of subjects: 60
Study 21648052 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare metal renal artery stenting
Number of subjects: 286
Study 19229549 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin (100 microg IV injection)
Number of subjects: 104
Study 19229549 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin (10 IU IV infusion over 2 hours)
Number of subjects: 104
Study 16508386 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib 40 mg
Number of subjects: 30
Study 16508386 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 30 mg
Number of subjects: 30
Study 16508386 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free normal saline (placebo)
Number of subjects: 30
Study 12871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 20 mg
Number of subjects: 60
Study 12871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 40 mg
Number of subjects: 60
Study 12871368 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 80 mg
Number of subjects: 60
Study 12871368 — intervention group
Group type: EXPERIMENTAL
Intervention: r-Hirudin
Number of subjects: 60
Study 11908372 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Actibrush battery‐powered toothbrush
Number of subjects: 0
Study 11908372 — intervention group
Group type: COMPARATOR
Intervention: Dr. Best Flex Toothbrush (Germany)
Number of subjects: 0
Study 11908372 — intervention group
Group type: COMPARATOR
Intervention: Reach Triple Action Ultra Clean Toothbrush (Germany)
Number of subjects: 0
Study 11908372 — intervention group
Group type: COMPARATOR
Intervention: Jordan Multi‐Action Toothbrush (Norway)
Number of subjects: 0
Study 11908372 — intervention group
Group type: COMPARATOR
Intervention: Sanogyl Systeme In'Side Double Action Toothbrush (France)
Number of subjects: 0
Study 8932891 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine (0.8 g/kg body weight/day)
Number of subjects: 11
Study 1415392 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg)
Number of subjects: 30
Study 1415392 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg)
Number of subjects: 30
Study 1415392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 4064532 — intervention group
Group type: EXPERIMENTAL
Intervention: Buscopan (20 mg)
Number of subjects: 114
Study 4064532 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (0.5 mg)
Number of subjects: 114